Ang II receptor blockers and ACE inhibitors have been shown to lower resting MSNA and blood pressure but neither normalizes MSNA in CKD and thus, other therapeutic strategies are needed [15,16]. The gene discussed is ACE; the disease is chronic kidney disease.